Institutional interest in the "trump stock price" is rising, with hedge funds increasing exposure in anticipation of policy-aligned sectors benefiting from a potential political shift. Relative Strength Index trends remain above 60, hinting at strength. The current polarization could be a distant memory in a few years. If so (and maybe even if not), I suspect that long-term investors have a decent shot at winning with Disney stock. The move represents one of the largest White House efforts to influence drug costs in recent years. Trump indicated the government expects to secure further pricing commitments from other major drugmakers following Pfizer's participation. That positioning underscores trader expectations for continued upside momentum.